[Anatomo-clinical aspects of Parkinson's disease and parkinsonian syndromes].
D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000150:complications*; D001930:Brain Injuries / Q000150:complications; D001932:Brain Neoplasms / Q000150:complications*; D002090:Butyrophenones / Q000009:adverse effects; D002526:Cerebellar Diseases / Q000150:complications; D002561:Cerebrovascular Disorders / Q000150:complications; D003704:Dementia / Q000150:complications; D003711:Demyelinating Diseases / Q000150:complications; D064420:Drug-Related Side Effects and Adverse Reactions; D004409:Dyskinesia, Drug-Induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000150:complications; D010300:Parkinson Disease / Q000209:etiology / Q000473:pathology; D010301:Parkinson Disease, Postencephalitic / Q000473:pathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000209:etiology / Q000473:pathology; D010640:Phenothiazines / Q000009:adverse effects; D011041:Poisoning / Q000150:complications; D012110:Reserpine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D002090:Butyrophenones; D010640:Phenothiazines; D014149:Tranquilizing Agents; D012110:Reserpine
Aspetti anatomo-clinici del morbo di Parkinson e delle sindromi parkinsoniane.